STAT+: Pharmalittle: We’re reading about Medicaid and sickle cell, pharma CEOs, and more
U.S. policymakers, government officials, and patients are uncertain how Medicaid will cope with the budget strain of new gene therapies for sickle cell disease.
by Ed Silverman
Jan 29, 2024
1 minute
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of online meetings, phone calls, and deadlines has returned. But you
You’re reading a preview, subscribe to read more.
Start your free 30 days